{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:05:57Z","timestamp":1762520757805,"version":"3.41.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1023\/a:1007493003891","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T04:48:21Z","timestamp":1040532501000},"page":"363-372","source":"Crossref","is-referenced-by-count":6,"title":["Antacid (A02A) and antiulcer (A02B) drug prescription patterns: Predicting factors, dosage and treatment duration"],"prefix":"10.1007","volume":"14","author":[{"given":"M.M. Morales","family":"Su\u00e1rez\u2013Varela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"P\u00e9rez\u2013Benajas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.J. Girbes","family":"Pelechano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Llopis\u2013Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"8","key":"163125_CR1","first-page":"904","volume":"114","author":"R Haaverstad","year":"1994","unstructured":"Haaverstad R, Moen OO, Kannclonning KS, Line PD, et al. Ulcer surgery and anti-ulcer agents. Changes in surgical activities and sale of antiulcer agents in Nord Trodelang 1975\u20131989. Tidsskr Nor Laegeforen 1994 Mar. 20; 114(8): 904\u2013907.","journal-title":"Tidsskr Nor Laegeforen"},{"key":"163125_CR2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00004836-198606002-00006","volume":"8","author":"BI Hischowitz","year":"1986","unstructured":"Hischowitz BI, Berenson MM, Berkowitz JM, Briht-Asare P, et al. A multicenter study of ranitidine treatment of duodenal ulcers in the United states. J Clin Gastroenterol 1986; 8: 359\u2013366.","journal-title":"J Clin Gastroenterol"},{"key":"163125_CR3","first-page":"27","volume":"39","author":"EC. Klikenberg-Knoll","year":"1992","unstructured":"Klikenberg-Knoll EC. The role of omeprazole in healing and prevention of reflux disease. Hepatogastroenterology 1992; 39: 27\u201333.","journal-title":"Hepatogastroenterology"},{"key":"163125_CR4","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/S0140-6736(81)92472-7","volume":"1","author":"JH Wyllie","year":"1981","unstructured":"Wyllie JH, Clark CG, Alexander J, Bell K, et al. Effect of cimetidine on surgery for duodenal ulcer. Lancet 1981; 1: 1307\u20131308.","journal-title":"Lancet"},{"key":"163125_CR5","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/S0140-6736(81)92471-5","volume":"1","author":"HV Finneberg","year":"1981","unstructured":"Finneberg HV, Pearlmann LA. Surgical treatment of peptic ulcer in the United States. Trends before and after the introduction of cimetidine. Lancet 1981; 1: 1305\u20131307.","journal-title":"Lancet"},{"key":"163125_CR6","first-page":"1766","volume":"47","author":"D Raisch","year":"1990","unstructured":"Raisch D, Bootman L, Larson N, McGhan W. Improving antiulcer agent prescribing in a health maintenance organization. Am J Hosp Pharm 1990; 47: 1766\u20131773.","journal-title":"Am J Hosp Pharm"},{"key":"163125_CR7","first-page":"466","volume":"22","author":"A Mead","year":"1988","unstructured":"Mead A, McGhan W. Use of histamine 2-receptor blocking agents and sucralfate in a health maintenance organization following continued clinical pharmacist intevention. DICD 1988; 22: 466\u2013499.","journal-title":"DICD"},{"key":"163125_CR8","volume-title":"Gu\u00eda farmacol\u00f3gica para la asistencia primaria","author":"Ministerio de Sanidad y Consumo.","year":"1987","unstructured":"Ministerio de Sanidad y Consumo. Gu\u00eda farmacol\u00f3gica para la asistencia primaria. Madrid: Ministerio de sanidad y Consumo, 1987."},{"key":"163125_CR9","volume-title":"Gu\u00eda farmaterapeutica geriatrica","author":"Generalitat Valenciana.","year":"1990","unstructured":"Generalitat Valenciana. Gu\u00eda farmaterapeutica geriatrica. Valencia: Residencia Asistida de Carlet, 1990."},{"key":"163125_CR10","first-page":"190","volume":"63","author":"J Casas","year":"1983","unstructured":"Casas J, Caro-Patow A, Jimenez M. Estudio de la capacidad neutrahzante \u2018in vitro\u2019 de diversas especialidad farmac\u00e9uticas anti\u00e1cidas en el mercado espa\u00f1ol. Implicaciones pr\u00e1cticas. Rev Esp Enf Ap Digest 1983; 63: 190.","journal-title":"Rev Esp Enf Ap Digest"},{"key":"163125_CR11","first-page":"187","volume-title":"Terap\u00e9utica en gastroenterolog\u00eda","author":"V. Jimenez","year":"1986","unstructured":"Jimenez V. Los anti\u00e1cidos en terap\u00e9uticas: criterios de calidad. In: Terap\u00e9utica en gastroenterolog\u00eda. Valencia: Ed. Jarypo, 1986; 187\u2013198."},{"key":"163125_CR12","volume-title":"Principios de la epidemiolog\u00eda de los medicamentos","author":"JR Laporte","year":"1983","unstructured":"Laporte JR, Tognoni G. Principios de la epidemiolog\u00eda de los medicamentos. Barcelona: Salvat Ediciones, 1983."},{"issue":"3","key":"163125_CR13","first-page":"218","volume":"11","author":"MC Aguil\u00f3","year":"1994","unstructured":"Aguil\u00f3 MC, Bofill C, Riera P. Farmacoterapia analg\u00e9sica en la asistencia primaria. Aproximaci\u00f3n a una valoraci\u00f3n desde la farmacia comunitaria. Farm Clin 1994; 11(3): 218\u2013234.","journal-title":"Farm Clin"},{"key":"163125_CR14","volume-title":"Conseller\u00e1 de Sanitat i Consum. Libro blanco de la salud en la Comunidad Valenciana","author":"Generalitat Valenciana","year":"1991","unstructured":"Generalitat Valenciana, Conseller\u00e1 de Sanitat i Consum. Libro blanco de la salud en la Comunidad Valenciana. Valencia: Generalitat Valenciana, 1991."},{"key":"163125_CR15","volume-title":"Clasificaci\u00f3n Internacional de Enfermedades, IX Revisi\u00f3n, Modificaci\u00f3n cl\u00ednica","author":"Instituto Nacional de la Salud, Ministerio de Sanidad y Consumo.","year":"1989","unstructured":"Instituto Nacional de la Salud, Ministerio de Sanidad y Consumo. Clasificaci\u00f3n Internacional de Enfermedades, IX Revisi\u00f3n, Modificaci\u00f3n cl\u00ednica. Madrid: Instituto Nacional de la Salud, 1989."},{"key":"163125_CR16","volume-title":"Catalogo de especialidades farmac\u00e9uticas 1992","author":"Departamento T\u00e9cnico del Consejo General de Colegios Oficiales de Farmac\u00e9uticos","year":"1992","unstructured":"Departamento T\u00e9cnico del Consejo General de Colegios Oficiales de Farmac\u00e9uticos, Catalogo de especialidades farmac\u00e9uticas 1992. Madrid: Consejo General de Colegios Oficiales de Farmac\u00e9uticos, 1992."},{"issue":"2","key":"163125_CR17","first-page":"96","volume":"6","author":"MA Mart\u00ednez","year":"1989","unstructured":"Mart\u00ednez MA, P\u00e9rez C, Jim\u00e9nez NV, et al. Auditor\u00eda terap\u00e9utica para los medicamentos antiacidos. Farm Clin 1989; 6(No. 2): 96\u2013108.","journal-title":"Farm Clin"},{"issue":"6","key":"163125_CR18","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/ije\/23.6.1262","volume":"23","author":"AE. Eggen","year":"1994","unstructured":"Eggen AE. Pattern of drug use in a general population. Prevalence and predicting factors: The Tromso Study. International Journal of Epidemiology 1994; 23(6): 1265\u20131271.","journal-title":"International Journal of Epidemiology"},{"issue":"2","key":"163125_CR19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2036.1995.tb00362.x","volume":"9","author":"SJ Roberts","year":"1995","unstructured":"Roberts SJ, Baterman DN. Prescribing of antacids and ulcer healing drugs in primary care in the North of England. Aliment Pharmacol Ther 1995 Apr.; 9(2): 137\u2013143.","journal-title":"Aliment Pharmacol Ther"},{"issue":"March 26","key":"163125_CR20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bmj.308.6932.827","volume":"308","author":"SD Ryder","year":"1994","unstructured":"Ryder SD, O'Reilly S, Miller RJ, et al. Long-term acid suppressing treatment in general practice. Br Med J 1994; 308 (March 26): 827\u2013830.","journal-title":"Br Med J"},{"key":"163125_CR21","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3109\/00365529409094875","volume":"29","author":"H Thors","year":"1994","unstructured":"Thors H, Sigurdsson H, Oddsson E, et al. Survey of pre scriptions for peptic ulcer drugs (ACT Class AOB2) in Iceland. Scan J Gastroenterol 1994; 29: 988\u2013994.","journal-title":"Scan J Gastroenterol"},{"key":"163125_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0140-6736(81)90267-1","volume":"2","author":"KD Bardham","year":"1981","unstructured":"Bardham KD, Hinchliffe RFC. Effect of cimetidine on surgery of duodenal ulcer. Lancet 1981; 2: 38.","journal-title":"Lancet"},{"key":"163125_CR23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/02813438809009289","volume":"6","author":"T. Klaukka","year":"1988","unstructured":"Klaukka T. Users of prescription drugs in Finnish primary care. Scan J Prim Health Care 1988; 6: 43\u201350.","journal-title":"Scan J Prim Health Care"},{"key":"163125_CR24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00005650-199305000-00006","volume":"31","author":"T Klaukka","year":"1993","unstructured":"Klaukka T, Makela M, Sipila J, Martikainen J. Multiuse of medicines in Finland. Med Care 1993; 31: 445\u2013450.","journal-title":"Med Care"},{"key":"163125_CR25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF01319204","volume":"1","author":"DL Rabin","year":"1975","unstructured":"Rabin DL, Bush PJ. Who's using medicines? J Community Health 1975; 1: 106\u2013107.","journal-title":"J Community Health"},{"key":"163125_CR26","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2105\/AJPH.73.11.1312","volume":"73","author":"LF. Rossiter","year":"1983","unstructured":"Rossiter LF. Prescribed medicines: Findings from the national medical care expenditure survey. Am J Public Health. 1983; 73: 1312\u20131315.","journal-title":"Am J Public Health"},{"key":"163125_CR27","first-page":"1750","volume":"142","author":"N Norrelund","year":"1980","unstructured":"Norrelund N, Helles A, Schiegelow M. Uncharacteristic dyspepsia in general practice: A controlled trial with aluminium aminoacetate and magnesium hydroxide. Ugeskr Laeger 1980; 142: 1750\u20131753.","journal-title":"Ugeskr Laeger"},{"key":"163125_CR28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0016-5085(86)90451-8","volume":"91","author":"NJ Talley","year":"1986","unstructured":"Talley NJ, McNeil D, Hayden D, Piper DN. Randomized, double blind, placebo controlled cross-over trial of cimetidine and pirenzepine in non-ulcer dyspepsia. Gastroenterology 1986; 91: 149\u2013156.","journal-title":"Gastroenterology"},{"key":"163125_CR29","first-page":"327","volume":"23","author":"T Johannessen","year":"1988","unstructured":"Johannessen T, Fjosne U, Kleveland PM, Halvorsen PM, et al. Cimetidine responders in non-ulcer dyspepsia. Gastroenterol 1988; 23: 327\u2013336.","journal-title":"Gastroenterol"},{"key":"163125_CR30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/00365528809093840","volume":"23","author":"R Gotthard","year":"1988","unstructured":"Gotthard R, Bodemar G, Brodin U, Jonsson KA. Treatment with cimetidine, antacid or placebo in patients with dyspepsia of unknown origin. Scan J Gastroenterol 1988; 23: 7\u201318.","journal-title":"Scan J Gastroenterol"},{"issue":"20Suppl.","key":"163125_CR31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/00365528509103934","volume":"109","author":"O Nyren","year":"1985","unstructured":"Nyren O, Adami HO, Gustalson S, Loof L, et al. Social and economic effects of non-ulcer dyspepsia. Scand J Gastroenterol 1985; 20 Suppl. 109: 41\u201345.","journal-title":"Scand J Gastroenterol"},{"key":"163125_CR32","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00004836-198910000-00003","volume":"11","author":"SJO Veldhusen van Zanten","year":"1989","unstructured":"Veldhusen van Zanten SJO, Tygat KMAJ, Jalai S. Goodacre RL. Can gastritis symptoms be evaluated in clinical trials? An overview of treatmen of gastritis and campylobacter-associated gastritis. J Clin Gastroenterol 1989; 11: 496\u2013501.","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"163125_CR33","first-page":"310","volume":"9","author":"MI Espinosa","year":"1992","unstructured":"Espinosa MI, Bad\u00eda MB, Buti\u00f1\u00e1 T, et al. Farmacoepide-miolog\u00eda de antiulcerosos. Estudio multic\u00e9ntrico. Farm Clin 1992; 9(4): 310\u2013315.","journal-title":"Farm Clin"},{"issue":"5","key":"163125_CR34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3109\/00365529509093304","volume":"30","author":"J Hallas","year":"1995","unstructured":"Hallas J, Lauritsen J, Villadsen HD, Gram LF. Nonsteroidal anti-inflamatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates. Scand J Gastroenterol 1995 May; 30(5): 438\u2013444.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"163125_CR35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00001648-199501000-00010","volume":"6","author":"G Traversa","year":"1995","unstructured":"Traversa G, Walker AM, Ippolito FM, Caffari B, et al. Gastroduodenal toxicity of different nonsteroidal anti-nflammatory drugs. Epidemiology 1995 Jan; 6(1): 49\u201354.","journal-title":"Epidemiology"},{"key":"163125_CR36","unstructured":"Le-Lorier J. Pattern of prescription of nonsteroidal anti-inflammatory drugs and gastroprotective agents. J Rheumatol Suppl. 1995 Feb.; 43: 26\u201327."},{"key":"163125_CR37","first-page":"633","volume":"84","author":"FL Lanza","year":"1989","unstructured":"Lanza FL, Farouhi D, Rubin A, Davis RE, et al. A double-blind placebo controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms. Am J Gastroenterol 1989; 84: 633\u2013636.","journal-title":"Am J Gastroenterol"},{"key":"163125_CR38","first-page":"462","volume":"i","author":"DY Graham","year":"1986","unstructured":"Graham DY, Agrawl NM, Roth S. Prevention of NSAID-induced gastric ulcer with misoprostol: A multicentre, double-blind, placebo controlled trial. Lancet 1986; i: 462\u2013464.","journal-title":"Lancet"},{"issue":"Suppl.","key":"163125_CR39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2036.1991.tb00756.x","volume":"5","author":"CP. Dooley","year":"1991","unstructured":"Dooley CP. Helicobacter pylori: review of research findings. Aliment Pharmacol Therap 1991; 5(Suppl.): 129\u2013143.","journal-title":"Aliment Pharmacol Therap"},{"key":"163125_CR40","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S0140-6736(94)91460-5","volume":"343","author":"SW. Hosking","year":"1994","unstructured":"Hosking SW. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: Randomised controlled trial. Lancet 1994; 343: 508\u2013510.","journal-title":"Lancet"},{"key":"163125_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1056\/NEJM199501193320302","volume":"332","author":"JJY. Sung","year":"1995","unstructured":"Sung JJY. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl Med 1995; 332: 139\u2013142.","journal-title":"N Engl Med"},{"key":"163125_CR42","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(95)92962-2","volume":"345","author":"WA. De Boer","year":"1995","unstructured":"De Boer WA. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: 817\u2013820.","journal-title":"Lancet"},{"key":"163125_CR43","unstructured":"Jimenez-Torres V. Utilizaci\u00f3n de medicamentos anti\u00e1cidos: farmacovigilancia. Zargoza: XXXI Congreso Nacional de la AEFH, 1987: 191\u2013198."},{"issue":"10","key":"163125_CR44","first-page":"824","volume":"4","author":"JC. L\u00f3pez","year":"1987","unstructured":"L\u00f3pez JC. \u00bfSe utilizan correctamente los medicamentos anti-\u00falcera p\u00e9ptica en Baleares? Farm Clin 1987; 4(10): 824\u2013833.","journal-title":"Farm Clin"},{"issue":"5","key":"163125_CR45","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00005650-199305000-00005","volume":"31","author":"RE Johnson","year":"1993","unstructured":"Johnson RE, McFarland BH. Antipsychotic drug exposure in a Health Maintenance Organization. Medical Care 1993; 31(5): 432\u2013444.","journal-title":"Medical Care"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007493003891.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007493003891\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007493003891.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T05:30:11Z","timestamp":1753853411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007493003891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["163125"],"URL":"https:\/\/doi.org\/10.1023\/a:1007493003891","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"type":"print","value":"0393-2990"},{"type":"electronic","value":"1573-7284"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}